Genfit
Develops drugs for the PREvention and treatment of cardiometabolic and neurodegenerative diseases
Genfit has raised €34M across 1 funding round, most recently a Growth/Late round in Oct 2016. Based in Loos, France; founded 1999; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€34M
€33,900,000
Funding rounds
1
Investors
0
distinct backers
Active since
2016-10
latest 2016-10
Funding by year
EUR raised per yearGenfit — funding by year — interactive chart.
Data table
| Genfit — funding by year | |
|---|---|
| 2016 | €34M |
Signals
Medium confidenceRaise-next likelihood7
base rate 37% for Growth/Late
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-10-01 | Growth/Late | €34M | — | View deal → |
Acquisitions
1- Versantis2022 · €41M
Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData